Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications-Reference-Cited by-同舟云学术

Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications

Published:2019-01-02 Issue:2 Volume:19 Page:79-88
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Savarino Edoardo¹^ORCID,Bertani Lorenzo²,Ceccarelli Linda²,Bodini Giorgia³,Zingone Fabiana¹,Buda Andrea¹,Facchin Sonia¹,Lorenzon Greta¹,Marchi Santino²^ORCID,Marabotto Elisa³,De Bortoli Nicola²,Savarino Vincenzo³^ORCID,Costa Francesco²,Blandizzi Corrado⁴

Affiliation:

1. Gastrointestinal Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

2. Gastrointestinal Unit, Division of Gastroenterology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

3. Gastrointestinal Unit, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy

4. Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1561852

Reference85 articles.

1. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review